This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.

 

This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Thomas Danne
Professor Thomas
Danne
Chief Physician Diabetes Center, Auf der Bult, Hannover, Germany

Professor Thomas Danne is Director of the Department of General Pediatrics and Endocrinology/Diabetology and Clinical Research at the Auf der Bult hospital for children and adolescents, Hannover Medical School, Germany, which is the largest paediatric diabetes centre in Germany. He trained at the Free University Berlin Children’s Hospital in Berlin and was Consultant Paediatrician at the Charité Children’s Hospital of Humboldt University, Berlin. He is a former research fellow of the Joslin Diabetes Center of Harvard Medical School in Boston, USA.

 

Presently, he is appointed as Chair of the SWEET registry (www.sweet-project.org) and Vice-Chair of INNODIA-iVZW (www.innodia.eu), a consortium to fight type 1 diabetes. He has served as Secretary General and President of the International Society for Pediatric and Adolescent Diabetes (ISPAD). Also, he is the past-president of the German Diabetes Association (DDG).

 

He has been awarded the Helmut Otto Medal of the DDG, the Somogyi Award of the Hungarian Diabetes Association, the ISPAD Prize of Achievement and the Lifetime Achievement Award of the International Diabetes Federation. His research interests include basic and clinical research in paediatric diabetology, with special emphasis on quality improvement through registers, new insulins, glucose sensors, insulin pumps and automated insulin delivery.